FDA Supports Recall of Bausch & Lomb's ReNu

Target net rises, but margins "unfavorable"; Boeing reportedly reaches settlement with Justice Dept; plus more stocks in the news Monday

From Standard & Poor's Equity Research

To continue reading this article you must be a Bloomberg Professional Service Subscriber.